Skeletal muscle mass as a prognostic indicator in resected pancreatic cancer patients

被引：0
|
作者：
Jongchan, Lee [1 ]
Jong-Chan, Lee [1 ]
In-Kuk, Cho [1 ]
Jaihwan, Kim [1 ]
Jin-Hyeok, Hwang [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-204
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer
    Lee, Jongchan
    Lee, Jong-chan
    Kim, Hyoung Woo
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    PLOS ONE, 2020, 15 (09):
  • [2] Postoperative early thromboembolism as a prognostic indicator in patients with curatively resected pancreatic cancer
    Hwang, In Kyeom
    Kang, Bong Kyun
    Lee, Yoon Suk
    Cho, Jai Young
    Yoon, Yoo-Seok
    Hwang, Jin-Hyeok
    Han, Ho-Seong
    Kim, Jaihwan
    AMERICAN JOURNAL OF SURGERY, 2015, 210 (05): : 871 - 877
  • [3] Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
    Shin, Dong Woo
    Kim, Minseok Albert
    Lee, Jong-chan
    Kim, Jaihwan
    Hwang, Jin-Hyeok
    BMC RESEARCH NOTES, 2021, 14 (01)
  • [4] Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
    Dong Woo Shin
    Minseok Albert Kim
    Jong-chan Lee
    Jaihwan Kim
    Jin-Hyeok Hwang
    BMC Research Notes, 14
  • [5] Early loss of skeletal muscle mass (LSMM) as prognostic factor in metastatic pancreatic cancer (PC) patients
    Basile, D.
    Parnofiello, A.
    Vitale, M. G.
    Cortiula, F.
    Garattini, S. K.
    Gerratana, L.
    Andreotti, V. J.
    Ongaro, E.
    Lisanti, C.
    Bartoletti, M.
    Bonotto, M.
    Fanotto, V.
    Cattaneo, M.
    Iacono, D.
    Bacco, A.
    Ermacora, P.
    Puglisi, F.
    Aprile, G.
    Pella, N.
    Cardellino, G. G.
    Fasola, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Association of Longitudinal Changes in Skeletal Muscle Mass With Survival in Patients With Pancreatic Cancer
    Lee, B.
    Namkoong, H.
    Yang, Y.
    Huang, H.
    Heller, D.
    Szot, G.
    Davis, M.
    Pandol, S. J.
    Bellin, M. D.
    Husain, S.
    Habtezion, A.
    PANCREAS, 2021, 50 (07) : 1073 - 1073
  • [7] Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis
    Rinninella, Emanuele
    Fagotti, Anna
    Cintoni, Marco
    Raoul, Pauline
    Scaletta, Giuseppe
    Scambia, Giovanni
    Gasbarrini, Antonio
    Mele, Maria Cristina
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (05) : 654 - 663
  • [8] Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant Therapy
    Trudeau, Maxwell T.
    Vollmer, Charles M., Jr.
    JAMA SURGERY, 2020, 155 (03) : 268 - 269
  • [9] Characterization of a loss of skeletal muscle mass in advanced pancreatic cancer patients receiving chemotherapy
    Tatematsu, Noriatsu
    Mitsunaga, Shuichi
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] THE IMPACT OF SKELETAL MUSCLE MASS LOSS IN PATIENTS WITH ADVANCED PANCREATIC CANCER DURING FOLFIRINOX
    Uemura, Shinya
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Mita, Naoki
    Shimizu, Masahito
    GASTROENTEROLOGY, 2020, 158 (06) : S863 - S863
12345